Point72 Asset Management, L.P. 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 3:16 pm Sale | 2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Point72 Asset Management, L.P. | 3,691,632 2.100% | -4,696,422 (-55.99%) | Filing |